Stockreport

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

Koninklijke Philips N.V. NY Registry Shares  (PHG) 
US:NYSE Investor Relations: philips.com/a-w/about/investor.html
PDF With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the [Read more]